Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors

A series of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines, as exemplified by compound WR23, was synthesized and evaluated as PI3Kα inhibitors.